Suchergebnisse - (Person:"Bafadhel, Mona")

PubPharm (10)

1

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial

enthalten in: Annals of internal medicine | 2023

von Reis, G. | Dos Santos Moreira Silva, E. | Medeiros Silva, D. | +133

2

Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids : a mechanistic analysis

enthalten in: The Lancet. Respiratory medicine | 2022

von Baker, J. | Mahdi, M. | Nicolau, D. | +7

CommentIn: Lancet Respir Med. 2022 Jun;10(6):526-527. - PMID 35397799

3

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

enthalten in: Annals of the American Thoracic Society | 2021

von Chipps, B. | Jarjour, N. | Calhoun, W. | +7

4

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial

enthalten in: Lancet (London, England) | 2021

von Yu, L. | Bafadhel, M. | Dorward, J. | +50

CommentIn: Lancet. 2021 Sep 4;398(10303):818-819. - PMID 34388397

5

Inhaled budesonide in the treatment of early COVID-19 (STOIC) : a phase 2, open-label, randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Ramakrishnan, S. | Nicolau, D. | Langford, B. | +21

CommentIn: Lancet Respir Med. 2021 Apr 9;:. - PMID 33844998

6

Intravenous iron and chronic obstructive pulmonary disease : a randomised controlled trial

enthalten in: BMJ open respiratory research | 2020

von Santer, P. | McGahey, A. | Frise, M. | +6

7

Benralizumab for the Prevention of COPD Exacerbations

enthalten in: The New England journal of medicine | 2019

von Criner, G. | Celli, B. | Brightling, C. | +121

8

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease : a post-hoc analysis of three randomised trials

enthalten in: The Lancet. Respiratory medicine | 2018

von Bafadhel, M. | Peterson, S. | De Blas, M. | +4

CommentIn: Lancet Respir Med. 2018 Feb;6(2):78-80. - PMID 29331310

9

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia : a randomised, double-blind, placebo-controlled, phase 2a study

enthalten in: The Lancet. Respiratory medicine | 2014

von Brightling, C. | Bleecker, E. | Panettieri, R. | +6

CommentIn: Lancet Respir Med. 2014 Nov;2(11):862-3. - PMID 25306558

10

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease : a randomized placebo-controlled trial

enthalten in: American journal of respiratory and critical care medicine | 2012

von Bafadhel, M. | McKenna, S. | Terry, S. | +8

1
[1]